01B0V96J - Atopic dermatitis, an allergic skin rash, showing immune abnormalities at the cellular level and the gross pathology. Allergens activate mast cells, which then release mediators, thus promoting diapedesis of neutrophils. Phagocytes then release toxic oxygen damaging the epidermis. Atopic dermatitis is a form of eczema with itching and inflammation.

Applying Newer Biologic Therapies to Improve Outcomes in Patients with Atopic Dermatitis

Program Overview

This activity was derived from a live CME series at regional allergy and dermatology meetings. The expert faculty, Adaobi Nwaneshiudu, MD, PhD, will outline the pathogenesis of atopic dermatitis as it relates to the treatment and management of the disease. Clinical trial data of emerged and emerging therapies will be reviewed. Diagnostic criteria for members of the healthcare team managing patients with atopic dermatitis will be analyzed, and discrepancies addressed. Dr. Nwaneshiudu will convey optimal strategies for developing tailored treatment plans to improve outcomes in the short and long-term. At the conclusion of this educational offering, healthcare providers will have a better understanding of optimal treatment, monitoring and management techniques for atopic dermatitis.

Target Audience

Dermatologists, allergists, primary care physicians, nurse practitioners, nurses, and other healthcare professionals who care for patients with atopic dermatitis.

Learning Objectives

1. Discuss new treatments, signaling pathways and molecular actors that play a role in the pathogenesis of atopic dermatitis
2. Analyze clinical trial data for current and emerging therapeutics for the treatment of atopic dermatitis
3. Apply patient-specific, healthcare team based treatment plans to improve outcomes and the overall quality of life for patients with atopic dermatitis


nwaneshiudu_a_profileAdaobi Nwaneshiudu, MD, PhD
UT Health San Antonio
San Antonio, Texas




Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

FacultyRelationship Identified With:
Adaobi Nwaneshiudu, MD, PhDNothing to disclose.

Planners, Managers, Reviewers

Timothy Hayes, MD, PhD; Emma Gilmartin and Nicole Brestowski hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

AcademicCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Sanofi Genzyme and Regeneron Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
  6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.

CME Inquiries/Special Needs

For all CME inquiries or special needs, please contact [email protected]

This activity is expired for CE Credit